Products - Hypertension | Topic | NICE

Showing 8 products

Date | Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter

Sotatercept for treating pulmonary arterial hypertension [ID6163]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
15 October 2025
Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease ID6459
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
17 December 2025
Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Macitentant–tadalafil for treating pulmonary arterial hypertension [TSID10517]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Treprostinil diethanolamine for treating pulmonary arterial hypertension [TSID11772]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Macitentan for treating pulmonary arterial hypertension in people 1 month to 17 years [TSID11805]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Aprocitentan for treating resistant hypertension [TSID10395]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC